These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6389091)

  • 21. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
    Morton S; Lader M
    Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lorazepam in the treatment of neurosis.
    Lameiras JC
    Curr Med Res Opin; 1976; 4(6):441-5. PubMed ID: 11961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lorazepam in anxiety associated with chronic enteritis and ulcerative colitis.
    Stokes DK
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):53-7. PubMed ID: 30769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical assessment of lorazepam in anxiety: a double-blind study.
    Olgiati SG
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):13-22. PubMed ID: 237741
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam.
    Ceulemans DL; Hoppenbrouwers ML; Gelders YG; Reyntjens AJ
    Pharmacopsychiatry; 1985 Sep; 18(5):303-5. PubMed ID: 3931107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alprazolam in the treatment of neurotic anxiety.
    Kerry RJ; McDermott CM
    Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prazepam in the treatment of anxiety: a placebo-controlled multicenter evaluation.
    Weir JH
    J Clin Psychiatry; 1978 Dec; 39(12):841-7. PubMed ID: 721788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-blind videotaped evaluation of injectable diazepam, lorazepam and placebo.
    Bobon DP; Fanielle J; Mormont C; Breulet M; Bobon J
    Acta Psychiatr Belg; 1978; 78(4):619-34. PubMed ID: 31063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and tolerability of a standardized herbal product from Galphimia glauca on generalized anxiety disorder. A randomized, double-blind clinical trial controlled with lorazepam.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Morales-Valdéz M; García-Valencia CE; Tortoriello J
    Planta Med; 2007 Jul; 73(8):713-7. PubMed ID: 17562493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind study of prazepam versus placebo in single daily doses in the treatment of anxiety.
    Goldberg HL; Finnerty RJ
    Compr Psychiatry; 1977; 18(2):147-55. PubMed ID: 319941
    [No Abstract]   [Full Text] [Related]  

  • 32. Double-blind cross-over clinical comparison of two 2'-chloro benzodiazepines: 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one (chlordesmethyldiazepam) versus 7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam) in neurotic anxiety.
    Andreoli V; Maffei F; Montanaro N; Morandini G
    Arzneimittelforschung; 1977 Feb; 27(2):436-9. PubMed ID: 16622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies on the effects of the combination drug lorazepam plus diphenhydramine (Somnium) versus lorazepam on the noopsyche, thymopsyche and psychophysiology in nonorganic insomnia related to generalized anxiety disorder.
    Grünberger J; Saletu B; Linzmayer L; Böck G; Weissgram S; Brandstaätter N; Frey R; Saletu-Zyhlarz G
    Methods Find Exp Clin Pharmacol; 1997 Nov; 19(9):645-54. PubMed ID: 9500129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies with oral lorazepam in anxiety neurosis associated with depressive symptomatology.
    McCurdy L; Schatzberg AF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):30-4. PubMed ID: 30765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
    Petracca A; Nisita C; McNair D; Melis G; Guerani G; Cassano GB
    J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical symptomatology and computer analyzed EEG before, during and after anxiolytic therapy of alcohol withdrawal patients.
    Saletu M; Saletu B; Grünberger J; Mader R; Karobath M
    Neuropsychobiology; 1983; 9(2-3):119-34. PubMed ID: 6353268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lorazepam and diazepam in the treatment of neurotic anxiety: a double-blind trial.
    Valarino F; Perez-Lopez R
    Dis Nerv Syst; 1976 Feb; 37(2):58-61. PubMed ID: 1213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proceedings: Lorazepam in the treatment of neurosis--an uncontrolled clinical study.
    Ananth V; Beszterczy A; Geagea C
    Psychopharmacol Bull; 1976 Jan; 12(1):19-21. PubMed ID: 1825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.